Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anti-Human CD22 - APC - 200 µg | Login | Anti-Human CD22 - APC - 200 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD44 (Clone E1/2) - APC - 50 µg | Login | Anti-Human CD44 (Clone E1/2) - APC - 50 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD44 (Clone E1/2) - APC - 100 µg | Login | Anti-Human CD44 (Clone E1/2) - APC - 100 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD44 (Clone E1/2) - APC - 200 µg | Login | Anti-Human CD44 (Clone E1/2) - APC - 200 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD45 (Clone T29/33) - APC - 50 µg | Login | Anti-Human CD45 (Clone T29/33) - APC - 50 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD45 (Clone T29/33) - APC - 100 µg | Login | Anti-Human CD45 (Clone T29/33) - APC - 100 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD45 (Clone T29/33) - APC - 200 µg | Login | Anti-Human CD45 (Clone T29/33) - APC - 200 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD45RO (Clone UCHL-1) - APC - 50 µg | Login | Anti-Human CD45RO (Clone UCHL-1) - APC - 50 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD45RO (Clone UCHL-1) - APC - 100 µg | Login | Anti-Human CD45RO (Clone UCHL-1) - APC - 100 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD45RO (Clone UCHL-1) - APC - 200 µg | Login | Anti-Human CD45RO (Clone UCHL-1) - APC - 200 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD5 (Clone UCHT-2) - APC - 50 µg | Login | Anti-Human CD5 (Clone UCHT-2) - APC - 50 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD5 (Clone UCHT-2) - APC - 100 µg | Login | Anti-Human CD5 (Clone UCHT-2) - APC - 100 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD5 (Clone UCHT-2) - APC - 200 µg | Login | Anti-Human CD5 (Clone UCHT-2) - APC - 200 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD57 (Clone VC1.1) - APC - 50 µg | Login | Anti-Human CD57 (Clone VC1.1) - APC - 50 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD57 (Clone VC1.1) - APC - 100 µg | Login | Anti-Human CD57 (Clone VC1.1) - APC - 100 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD57 (Clone VC1.1) - APC - 200 µg | Login | Anti-Human CD57 (Clone VC1.1) - APC - 200 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CD24 (Heat Stable Antigen, Nectadrin) (Clone R7129.7) - APC - 25 µg | Login | Anti-Mouse CD24 (Heat Stable Antigen, Nectadrin) (Clone R7129.7) - APC - 25 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CD24 (Heat Stable Antigen, Nectadrin) (Clone R7129.7) - APC - 100 µg | Login | Anti-Mouse CD24 (Heat Stable Antigen, Nectadrin) (Clone R7129.7) - APC - 100 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CD4 [GK1.5] – APC - 50 µg | Login | Anti-Mouse CD4 [GK1.5] – APC - 50 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CD4 [GK1.5] – APC - 100 µg | Login | Anti-Mouse CD4 [GK1.5] – APC - 100 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CD45 (LCA) (Clone I3/2.3) - APC - 25 µg | Login | Anti-Mouse CD45 (LCA) (Clone I3/2.3) - APC - 25 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CD45 (LCA) (Clone I3/2.3) - APC - 100 µg | Login | Anti-Mouse CD45 (LCA) (Clone I3/2.3) - APC - 100 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CD8a (Ly 2) [53-6.7] – APC - 25 µg | Login | Anti-Mouse CD8a (Ly 2) [53-6.7] – APC - 25 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CD8a (Ly 2) [53-6.7] – APC - 100 µg | Login | Anti-Mouse CD8a (Ly 2) [53-6.7] – APC - 100 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse/Human CD45R (B220) (Clone RA3-6B2) - APC - 25 µg | Login | Anti-Mouse/Human CD45R (B220) (Clone RA3-6B2) - APC - 25 µg | ||||||||||||||||
|
||||||||||||||||||


